Advertisement

European Journal of Dermatology

, Volume 28, Issue 3, pp 422–423 | Cite as

A case of acquired haemophilia A in a patient with bullous pemphigoid and review of the Japanese literature

  • Chika Chijiwa
  • Masahiro Kamata
  • Atsuko Fukuyasu
  • Yuki Shono
  • Shintaro Takeoka
  • Mihoko Tateishi
  • Saki Fukaya
  • Kotaro Hayashi
  • Takamitsu Tanaka
  • Takeko Ishikawa
  • Takamitsu Ohnishi
  • Koji Saito
  • Norito Ishii
  • Takashi Hashimoto
  • Yayoi Tada
Correspondence
  • 10 Downloads

Supplementary material

40699_2018_3284_MOESM1_ESM.pdf (30 kb)
A case of acquired haemophilia A in a patient with bullous pemphigoid and review of the Japanese literature

References

  1. 1.
    Arakaki O, Yamamoto Y, Awazawa R, et al. Case of linear immunoglobulin A bullous dermatosis associated with acquired hemophilia. J Dermatol 2008; 35: 437–46.CrossRefPubMedGoogle Scholar
  2. 2.
    Binet Q, Lambert D, Sacre L, Eeckhoudt S, Hermans C. Successful management of acquired hemophilia A associated with bullous pemphigoid:a case report and review of the literature. Case Rep Hematol 2017; 2017: 2057019.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Caudron A, Chatelain D, Christophe O, Lok C, Roussel B, Viseux V. Favourable progression of acquired hemophilia–associated bullous pemphigoid. Eur J Dermatol 2009; 19: 383–4.PubMedGoogle Scholar
  4. 4.
    Dainichi T, Chow Z, Kabashima K. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid. J Dermatol Sci 2017; 88: 265–70.CrossRefPubMedGoogle Scholar
  5. 5.
    Dainichi T, Nishie W, Yamagami Y, et al. Bullous pemphigoid suggestive of complement–independent blister formation with anti–BP180 IgG4 autoantibodies. Br J Dermatol 2016; 175: 187–90.CrossRefPubMedGoogle Scholar
  6. 6.
    Dopp R, Schmidt E, Chimanovitch I, Leverkus M, Brocker EB, Zillikens D. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid:serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol 2000; 42: 577–83.PubMedGoogle Scholar
  7. 7.
    Laffitte E, Skaria M, Jaunin F, et al. Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses. Br J Dermatol 2001; 144: 760–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Lamb PM, Patton T, Deng JS. The predominance of IgG4 in prodromal bullous pemphigoid. Int J Dermatol 2008; 47: 150–3.CrossRefPubMedGoogle Scholar
  9. 9.
    Tiede A, Hofbauer C, Werwitzke S, et al. Anti–factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A:results from the GTH–AH 01/2010 study. Blood 2016; 127: 2289–97.CrossRefPubMedGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Chika Chijiwa
    • 1
  • Masahiro Kamata
    • 1
  • Atsuko Fukuyasu
    • 1
  • Yuki Shono
    • 1
  • Shintaro Takeoka
    • 1
  • Mihoko Tateishi
    • 1
  • Saki Fukaya
    • 1
  • Kotaro Hayashi
    • 1
  • Takamitsu Tanaka
    • 1
  • Takeko Ishikawa
    • 1
  • Takamitsu Ohnishi
    • 1
  • Koji Saito
    • 2
  • Norito Ishii
    • 3
  • Takashi Hashimoto
    • 4
  • Yayoi Tada
    • 1
  1. 1.Department of DermatologyTeikyo University School of MedicineTokyoJapan
  2. 2.Department of PathologyTeikyo University School of MedicineTokyoJapan
  3. 3.Department of DermatologyKurume University School of MedicineFukuokaJapan
  4. 4.Institute of Cutaneous Cell BiologyKurume University School of MedicineFukuokaJapan

Personalised recommendations